Compare American Well Corp (AMWL) vs Chevron Corp (CVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Chevron Corp — how do they compare? American Well Corp trades at $10.96 (market cap $165.58M), while Chevron Corp trades at $180.59 (market cap $351.32B). The key difference: Chevron Corp is far larger — about 2121.8× American Well Corp's market cap, and Chevron Corp pays a 4.04% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | CVX | |
|---|---|---|
Market Cap | $165.58M | $351.32B |
Sector | Health | Energy |
52-Week High | $9.91 | $211.14 |
52-Week Low | $3.78 | $146.72 |
Enterprise Value | -$9.66M | $391.42B |
Volume | — | 9,807,834 |
Dividend Yield | — | 4.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
CVX trades at $176.4, up 1.35% on the day, with a neutral technical signal and recent earnings beats. The stock shows strong analyst support (62% buy ratings) and a consensus price target of $207.56, implying 17.7% upside. Revenue declined to $184.43B in 2025, but operational cash flow remains robust at $33.94B. Recent news highlights geopolitical risks and Chevron's $13.8B investment in Argentina's Vaca Muerta shale project.
CVX offers value with a reasonable P/E of 30.73 and dividend yield, but faces headwinds from falling profit margins and oil price volatility. The stock's upside hinges on production growth and stable energy prices, while risks include geopolitical tensions and debt increases. Analyst optimism suggests potential gains if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Chevron Corp
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →
